Latest Sustainable Growth News

Australian Bond Exchange narrowed its FY25 loss by 26% through disciplined cost cuts and is advancing its fintech strategy with AI-driven credit tools and tokenised asset ambitions.

Wagners Holding Company Limited has reported a strong start to FY26 with robust demand across its construction materials and composite fibre technologies segments, prompting an upgrade to its EBIT guidance.

Lendlease has reported a return to profit in FY25 alongside significant capital recycling and board renewal, setting the stage for a strategic transition year in FY26 with a planned $500 million share buyback.

Veganic SKN Ltd has launched legal action against Cancer Council Australia over alleged misleading claims about chemical UV filters in sunscreens, coinciding with recent product recalls and the company’s ambitious growth plans for 2026.

Acrow Limited reported a 4% rise in underlying net profit for FY25, driven by strategic acquisitions and a growing industrial access division now contributing half of group revenue. Despite some formwork delays, the company maintains a strong project pipeline and steady dividends.

Matsa Resources has officially commenced gold production at its Devon Pit Gold Mine, marking a significant step forward in its Lake Carey Gold Project. With maiden reserves confirmed and a robust option agreement in place with AngloGold Ashanti, the company is poised for growth amid ongoing exploration success.

City Chic Collective has reversed its fortunes with a $15 million EBITDA turnaround in FY25, driven by strategic restructuring and strong ANZ growth. The company eyes a debt-free 2025 close and cash flow positivity in FY26 amid cautious optimism for US market expansion.

Resonance Health has revealed ambitious growth plans at its 2025 AGM, projecting revenue to nearly quadruple by FY26 while maintaining positive EBITDA guidance. The company is broadening its global footprint and diversifying its clinical trial services across multiple therapeutic areas.

Comms Group Limited reports a strong start to FY26 with a 41.6% revenue increase and successful integration of TasmaNet, positioning the company for ambitious annual targets.

NEXTDC’s FY25 Annual General Meeting reveals robust financial growth, significant data centre expansions, and enhanced funding capacity to capitalise on AI infrastructure demand.

ReNerve Limited’s innovative NervAlign® Nerve Cuff has secured approval for use across the US Department of Defense and Veterans Affairs healthcare systems, marking a major milestone for the Australian medtech company.

Lycopodium Limited projects steady growth for FY26 with revenue guidance of $390-$410 million, underpinned by strong project momentum and the strategic SAXUM acquisition expanding its footprint in the Americas.